JAMES LUCAS WAGONER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NACOGDOCHES, TX NPI 1104470988

General Payments — all program years on this page

$2,778.19

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 115
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $527.79 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $527.7920

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $204.446
ABBVIE INC. $196.056
Exact Sciences Corporation $49.643
Lilly USA, LLC $44.693
DEXCOM, INC. $19.241
Novo Nordisk AS $13.731

By program year

Program yearAmountRecords
2021 $1,040.7343
2022 $974.5140
2023 $235.1612
2024 $527.7920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100411406 Novo Nordisk Inc $13.73 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104470834 AstraZeneca Pharmaceuticals LP $23.81 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104475438 AstraZeneca Pharmaceuticals LP $14.81 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104608908 AstraZeneca Pharmaceuticals LP $124.99 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104756498 AstraZeneca Pharmaceuticals LP $16.66 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104762990 AstraZeneca Pharmaceuticals LP $15.92 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105874563 AstraZeneca Pharmaceuticals LP $8.25 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108369359 ABBVIE INC. $19.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108369361 ABBVIE INC. $124.99 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108369363 ABBVIE INC. $21.84 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108369365 ABBVIE INC. $7.73 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108369367 ABBVIE INC. $7.07 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108369369 ABBVIE INC. $15.42 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114508923 Exact Sciences Corporation $15.31 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114508929 Exact Sciences Corporation $16.00 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114508935 Exact Sciences Corporation $18.33 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135642288 Lilly USA, LLC $14.46 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135687902 Lilly USA, LLC $15.07 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135707082 Lilly USA, LLC $15.16 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153364146 Dexcom, Inc. $19.24 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.